Corgenix Medical announces CE Mark notification for TxBCardio assay Corgenix Medical Corporation announced in collaboration with Randox Laboratories that Randox has been granted CE Mark notification for its TxBCardio Assay. The TxBCardio test measures urinary levels of the thromboxane metabolite 11dhTxB2 to determine aspirin effect in apparently healthy individuals. CE mark designation enables commercial marketing and distribution of the product in Europe.
News For CONX From The Last 14 Days
Check below for free stories on CONX the last two weeks.